期刊文献+

血清肺表面活性蛋白A动态变化与非小细胞肺癌患者放射性肺炎发生的相关研究 被引量:1

Study of Correlation between Pulmonary Surfactant A Levels in Serum and Radiation Pneumonitis in Patients with Non-Small Cell Lung Cancer
原文传递
导出
摘要 目的:探讨接受放疗的非小细胞肺癌(NSCLC)患者血清中肺表面活性蛋白A(PS-A)水平的动态变化与放射性肺炎(RP)发生的关系。方法:对68例接受三维适形放疗的Ⅲ期肺癌患者采用酶联免疫吸附法(ELISA)检测于放疗前、放疗剂量达40~50 Gy时及放疗后4周血清中PS-A水平。结果:25例患者发生RP。RP者中放疗前PS-A为(38.6±20.8)ng/mL,放疗中升高达(51.4±19.3)ng/mL(P<0.05),放疗后PS-A高于放疗前[(78.2±21.5)ng/mL;P<0.05]。在无RP者中放疗前PS-A与放疗中、后均相似(P>0.05)。RP者与无RP者中放疗前PS-A相似(P>0.05),放疗中及放疗后前者PS-A明显高于后者(P<0.05)。结论:PS-A水平变化与RP发生密切相关,动态监测其变化可早期预测RP发生,可作为急性放射性肺损伤易感性指标。 Objective: To correlate the pulmonary surfactant A(PS-A) levels in non-small cell lung cancer(NSCLC)patients during 3-dimensional conformal radiation therapy(3-DCRT) with the occurrence of radiation pneumonitis(RP). Methods: Sixty-eight patients of lung cancer stagelIIwere evaluated prospectively by enzyme-linked immunosorbent assay(ELISA) for serum PS-A levels before 3-DCRT after 40-50 Gy and 4 weeks after 3-DCRT. Results: Twenty-five patients had RP. In RP patients, the serum PS-A level was(38.6+ 20.8) ng/mL, PS-A increased to(51.4± 19.3)ng/mL(P〈0.05)after 40-50 Gy. After 3-DCRT PS-A was higher(78.2± 21.5)ng/mL than that before 3-DCRT (P〈0.05). In non-RP patients, PS-A wags not yet change in three times (P〉0.05). PS-A was not yet change between RP and non-RP patients before 3-DCRT(P〉0.05), and PS-A was higher in RP group than that in non-RP group after 40-50Gy and 3-DCRT (P〈0. 05). Conclusions: The levels of PS-A are closely related to the occurrence of RP. Monitoring the changes in dynamic stale Could predict the generation of RP, which could be employed as sensitive index for indicating risks for acute RP.
机构地区 南京市胸科医院
出处 《现代生物医学进展》 CAS 2013年第2期269-271,共3页 Progress in Modern Biomedicine
关键词 放射性肺炎 肺表面活性蛋白A 非小细胞肺癌 动态变化 Rdiation pneumonitis Pulmonary surfactant A Non-small cell lung cancer Dynamics
  • 相关文献

参考文献17

  • 1Walther F J, Waring A J, Sherman MA, et al. Hydrophobic surfactant proteins and their analogues[J]. Neonatology, 2007, 91(4): 303-310.
  • 2Behterbos JBA, Heemabergen WD, Jaeger KD, et al. Final results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2006, 66(1): 126-113.
  • 3Kim DW, Shyr Y, Chen HD, et al. Repose to combined modality ther- apy correlates with survival in locally advanced non-small cell lung cancer[J]. Int J Radiat Oncol B iol Phys, 2005, 63(4): 1029-1036.
  • 4付和谊,卢冰,周华宁,欧阳伟炜,苏胜发,胡银祥,甘家应,吴伟莉,栗蕙芹.Ⅳ期非小细胞肺癌同期化放疗的临床结果分析[J].中华放射肿瘤学杂志,2009,18(1):52-56. 被引量:32
  • 5Bradley JD, Ieumwananonthachai N, Purdy JA, et al. Grosstumor vol- ume,critical prognosic factor in patients treated with three-dimensional conformal radiation therapy for non-small cell lung carcinooma[J].Int J Radiat On col Biol Phys, 2002, 52(1): 49-57.
  • 6Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with in- operable/unresectable non-small-cell lung cancer:long-term results of a radiation dose escalation study [J]. Int J Radiat Oncol Biol Phys, 2005, 63(2): 324-333.
  • 7Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG93-11: a phase I-lI dose-escalation study using three-dimen- sional conformal radiotherapy in patients with inoperable non-small cell lung carcinoma[J]. Int J Radiat Phys, 2005, 61(2): 318-328.
  • 8Rodrigues G, Lock M, D'Sonza D, et al. Prediction of radiation pneu- monitis by dose-volume histogram parameters in lung cancer-a sys- tematic review[J]. Badiother Oncol, 2004, 71(2): 127-138.
  • 9D'angio CT, Finkelstein JN, Lononaco MB, et al. Changes in surfac- tant protein gene expression in a neonatal rabbit model of hyperoxia- induced fibrosis[J]. Am J Physiol, 1997, 272(4ptl): L720-L730.
  • 10Sasaki R, Socjima T, Matsumoto A, et al. Clinical significance of serum pulmonary surfactant protein A and D for the early detection of radiation pneumonitis [J]. Int J Radiat Oncol Biol Phy, 2001, 50(2): 301-307.

二级参考文献57

  • 1欧阳伟炜,卢冰,何常,龙义国,王平.区域淋巴结微小转移对非小细胞肺癌临床分期的影响[J].中华放射肿瘤学杂志,2007,16(4):246-249. 被引量:4
  • 2Joan H,Schiller.晚期非小细胞肺癌的化疗// Harver I. Pass,James B. Mitchell, David H. Johnson, et al,主编.Lung Cancer.冯玉麟,刘春涛译.北京:人民卫生出版社,2002:819-832.
  • 3Massarelli E,Andre F,Liu DD,et al. A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small- cell lung cancer. Lung Cancer,2003,39:55-61.
  • 4Loriot Y, Sofia JC, Le Chevalier T. Expanding role of chemotherapy in lung cancer. Annal Oncol,2006,17 Suppl 10: 101-107.
  • 5ASTRO. Proceedings of the American society. Int J Radiat Oncol Biol Phys,2006,66 Suppl 3 : 253-2518.
  • 6ASTRO. Proceedings of the American society. Int J Radiat Oncol Biol Phys,2007,69 Suppl 3 : 257-2589.
  • 7Jett JR,Midthun D, Crowley JJ,et al. 12th World Conference on Lung Cancer. J Thoracic Oncol,2007,2 ( 8 Suppl) : S137-S852.
  • 8Burr M, Wronski M, Arbit E, et al. Resection of brain metastases from non-small cell lung carcinoma. Results of therapy. J Thorac Cardiovasc Surg, 1992,103:399-411.
  • 9Reyes L, Parvez Z, Nemoto T, et al. Adrenalectomy for adrenal metastasis from lung carcinoma. J Surg Oncol, 1990,44:32-34.
  • 10Belderbos JSA, Heemsbergen WD, Jaeger KD, et al. Final results of a phase Ⅰ /Ⅱ dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys ,2006,66 : 126-134.

共引文献67

同被引文献11

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部